Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q3 2024 Earnings Call Transcript November 13, 2024
Mersana Therapeutics, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-0.17.
Operator: Good morning, and welcome to Mersana Therapeutics Third Quarter 2024 Conference Call. Currently all participants are in listen-only mode. There will be a question-and-answer session at the end of this call. [Operator Instructions] Please note this event is being recorded. I would now...
